Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Oramed Pharmaceuticals Inc. ORMP

Full chart Compare
Set alert

Price alert · ORMP

All alert types
4.13 USD +0.13 (+3.25%)

At closeNov 4, 2026, 4:02 PM EST

4.13 0.00 0.00%

After hours · Nov 4, 4:02 PM ET

4.05 Day range 4.14
2.09 52-week range 5.47
YTD
+44.91%
1 year
+81.14%

Financial health

Altman Z-Score

3.38 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

S-5 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 5
  • P/E 4
  • P/B 5

Valuation

P/E 1.9×
FY 2015: -8.3×FY 2016: -10.9×FY 2017: -5.8×FY 2018: -4.0×FY 2019: -6.2×FY 2020: -25.2×FY 2022: -12.4×FY 2023: 16.5×FY 2024: -5.0×FY 2025: 1.9×
FY 2015 5y median -5.0× FY 2025
P/S 59.0×
FY 2015: 142×FY 2016: 46.9×FY 2017: 30.1×FY 2018: 21.4×FY 2019: 26.4×FY 2020: 207×FY 2022: 174×FY 2023: 69.5×FY 2024: 0.0×FY 2025: 59.0×
FY 2015 5y median 69.5× FY 2025
P/B 0.6×
FY 2015: 3.5×FY 2016: 6.0×FY 2017: 2.4×FY 2018: 3.0×FY 2019: 2.2×FY 2020: 4.8×FY 2022: 3.1×FY 2023: 0.6×FY 2024: 0.7×FY 2025: 0.6×
FY 2015 5y median 0.7× FY 2025
P/FCF -10.7×
FY 2015: 19.6×FY 2016: -19.7×FY 2017: -5.0×FY 2018: -4.5×FY 2019: -5.7×FY 2020: -26.0×FY 2022: -16.1×FY 2023: -8.8×FY 2024: -11.7×FY 2025: -10.7×
FY 2015 5y median -11.7× FY 2025
EV/EBITDA 1.0×
FY 2015: -8.7×FY 2016: -10.3×FY 2017: -5.1×FY 2018: -3.9×FY 2019: -4.5×FY 2020: -20.0×FY 2022: -10.6×FY 2023: 18.5×FY 2024: -3.0×FY 2025: 1.0×
FY 2015 5y median -3.0× FY 2025
EV/Sales 36.4×
FY 2015: 136×FY 2016: 45.3×FY 2017: 28.0×FY 2018: 20.2×FY 2019: 19.3×FY 2020: 179×FY 2022: 159×FY 2023: 101×FY 2024: 0.0×FY 2025: 36.4×
FY 2015 5y median 101× FY 2025
FCF Yield -9.4%
FY 2015: 5.1%FY 2016: -5.1%FY 2017: -19.9%FY 2018: -22.4%FY 2019: -17.5%FY 2020: -3.8%FY 2022: -6.2%FY 2023: -11.3%FY 2024: -8.5%FY 2025: -9.4%
FY 2015 5y median -8.5% FY 2025

Profitability

Gross Margin 0.7%
FY 2015: 23.6%FY 2016: 92.4%FY 2017: 96.5%FY 2018: 96.7%FY 2019: 100.0%FY 2020: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 0.7%
FY 2015 5y median 100.0% FY 2025
Operating Margin -754.4%
FY 2015: -1561.6%FY 2016: -438.6%FY 2017: -552.3%FY 2018: -541.3%FY 2019: -433.8%FY 2020: -896.2%FY 2022: -1502.0%FY 2023: -1176.8%FY 2024: 0.0%FY 2025: -754.4%
FY 2015 5y median -896.2% FY 2025
Net Margin 3202.5%
FY 2015: -1710.5%FY 2016: -426.7%FY 2017: -519.7%FY 2018: -531.1%FY 2019: -424.8%FY 2020: -822.7%FY 2022: -1397.1%FY 2023: 412.3%FY 2024: 0.0%FY 2025: 3202.5%
FY 2015 5y median 0.0% FY 2025
ROE 32.1%
FY 2015: -41.9%FY 2016: -54.5%FY 2017: -40.9%FY 2018: -74.0%FY 2019: -35.0%FY 2020: -19.2%FY 2022: -24.9%FY 2023: 3.4%FY 2024: -13.0%FY 2025: 32.1%
FY 2015 5y median -13.0% FY 2025
ROIC -6.0%
FY 2015: -25.5%FY 2016: -32.1%FY 2017: -29.6%FY 2018: -49.8%FY 2019: -29.3%FY 2020: -19.9%FY 2022: -26.0%FY 2023: -7.2%FY 2024: -8.5%FY 2025: -6.0%
FY 2015 5y median -8.5% FY 2025
ROA 27.7%
FY 2015: -25.6%FY 2016: -27.1%FY 2017: -26.9%FY 2018: -41.4%FY 2019: -25.8%FY 2020: -17.4%FY 2022: -23.4%FY 2023: 2.5%FY 2024: -12.3%FY 2025: 27.7%
FY 2015 5y median -12.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2015: 0.0%FY 2016: 283.2%FY 2017: -0.3%FY 2018: 10.4%FY 2019: 0.3%FY 2020: -0.3%FY 2022: 0.0%FY 2023: -50.4%FY 2024: -100.0%FY 2025: 0.0%
FY 2015 FY 2025
Operating Income -18.1%
FY 2015: -35.6%FY 2016: -7.6%FY 2017: -25.6%FY 2018: -8.2%FY 2019: 19.6%FY 2020: -106.0%FY 2022: 0.0%FY 2023: 61.2%FY 2024: 18.9%FY 2025: -18.1%
FY 2015 FY 2025
EPS (diluted) 412.5%
FY 2015: -29.9%FY 2016: 9.2%FY 2017: -8.9%FY 2018: 4.7%FY 2019: 31.7%FY 2020: -39.3%FY 2022: 0.0%FY 2023: 114.4%FY 2024: -442.9%FY 2025: 412.5%
FY 2015 FY 2025
Free Cash Flow -31.4%
FY 2015: 193.9%FY 2016: -225.7%FY 2017: -151.1%FY 2018: 11.6%FY 2019: 3.3%FY 2020: -72.1%FY 2022: 0.0%FY 2023: 63.9%FY 2024: 20.1%FY 2025: -31.4%
FY 2015 FY 2025

Financial Health

Current Ratio 7.0×
FY 2015: 8.6×FY 2016: 3.9×FY 2017: 6.8×FY 2018: 6.3×FY 2019: 8.9×FY 2020: 14.3×FY 2022: 27.3×FY 2023: 3.1×FY 2024: 25.2×FY 2025: 7.0×
FY 2015 5y median 14.3× FY 2025
Quick Ratio 7.0×
FY 2015: 8.6×FY 2016: 3.9×FY 2017: 6.8×FY 2018: 6.3×FY 2019: 8.9×FY 2020: 14.3×FY 2022: 27.3×FY 2023: 3.1×FY 2024: 25.2×FY 2025: 7.0×
FY 2015 5y median 14.3× FY 2025
Debt / Equity 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2022: 0.0×FY 2023: 0.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
Net Debt / EBITDA -0.6×
FY 2015: 0.4×FY 2016: 0.4×FY 2017: 0.4×FY 2018: 0.2×FY 2019: 1.6×FY 2020: 3.2×FY 2022: 1.0×FY 2023: 5.8×FY 2024: 3.6×FY 2025: -0.6×
FY 2015 5y median 3.2× FY 2025
Interest Coverage 0.0×
FY 2015: -910×FY 2016: -1795×FY 2017: -2255×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2022: 0.0×FY 2023: -4.4×FY 2024: -15.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31